Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Operational Update next post S&P 500 Bullish Patterns: Are Higher Highs Ahead? You may also like Q1 2025 Management’s Discussion and Analysis May 14, 2025 Allied Critical Metals Announces Corporate Update May 17, 2025 Should You Invest in Silver Bullion? June 6, 2025 Victoria Gold-Silver Exploration Update June 5, 2025 ARR advances permitting at Cowboy State Mine May 28, 2025 FireFly Metals to Add AU$95 Million to Coffers... June 12, 2025 Crypto Market Recap: Strategy Eyes US$1 Billion Capital... June 7, 2025 High-Grade Gold Samples extend Clifton East Strike to... May 22, 2025 Uranium Stocks: 5 Biggest Companies in 2025 May 20, 2025 Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts... May 24, 2025